Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review Ppublish 71 citations
PubMed: 35149239 DOI: 10.1016/j.coi.2022.01.003
Type I interferons and SARS-CoV-2: from cells to organisms.
Curr Opin Immunol 74:172-182
Authors: Paul Bastard, Qian Zhang, Shen-Ying Zhang, Emmanuelle Jouanguy, Jean-Laurent Casanova
Affiliations
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France; University of Paris, Imagine Institute, Paris, France; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA; Department of Pediatrics, Necker Hospital for Sick Children, AP-HP, Paris, France.
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France; University of Paris, Imagine Institute, Paris, France; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France; University of Paris, Imagine Institute, Paris, France; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA; Department of Pediatrics, Necker Hospital for Sick Children, AP-HP, Paris, France; Howard Hughes Medical Institute, New York, NY, USA.
Abstract
Type I interferons (IFNs) have broad and potent antiviral activity. We review the interplay between type I IFNs and SARS-CoV-2. Human cells infected with SARS-CoV-2 in vitro produce low levels of type I IFNs, and SARS-CoV-2 proteins can inhibit various steps in type I IFN production and response. Exogenous type I IFNs inhibit viral growth in vitro. In various animal species infected in vivo, type I IFN deficiencies underlie higher viral loads and more severe disease than in control animals. The early administration of exogenous type I IFNs improves infection control. In humans, inborn errors of, and auto-antibodies against type I IFNs underlie life-threatening COVID-19 pneumonia. Overall, type I IFNs are essential for host defense against SARS-CoV-2 in individual cells and whole organisms.
MeSH
Cells, Sars-Cov-2, Interferon Type I, Severe Acute Respiratory Syndrome-Related Coronavirus
Cited by
- Liver involvement and mortality in COVID-19: A retrospective analysis from the CORACLE study group. Infez Med, 2022
- Chest computed tomography characteristics of critically ill COVID-19 patients with auto-antibodies against type I interferons. Res Sq, 2023
- SARS-CoV-2 epitopes inform future vaccination strategies. Front Immunol, 2022
- A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist. PLoS Biol, 2024
- Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages. Nat Commun, 2024
- Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study. Ann Intensive Care, 2023
- Blood transcriptome responses in patients correlate with severity of COVID-19 disease. Front Immunol, 2023
- Nerve- and airway-associated interstitial macrophages mitigate SARS-CoV-2 pathogenesis via type I interferon signaling. Immunity, 2025
- Evolutionary divergence of induced versus constitutive antiviral gene expression levels between primates and rodents. PLoS Comput Biol, 2025
- Seven classes of antiviral agents. Cell Mol Life Sci, 2022
- The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. Proc Natl Acad Sci U S A, 2022
- Defective Immune Response to SARS-CoV-2 Immunization in Down Syndrome Correlates With Increased Susceptibility to Severe Illness With Infection. J Infect Dis, 2022
- Individual and Synergistic Anti-Coronavirus Activities of SOCS1/3 Antagonist and Interferon α1 Peptides. Front Immunol, 2022
- The antiviral state of the cell: lessons from SARS-CoV-2. Curr Opin Immunol, 2024
- Biological mechanisms underpinning the development of long COVID. iScience, 2023
- Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond. Cells, 2022
- Airways tissue expression of type I interferons and their stimulated genes is higher in children than adults. Heliyon, 2022
- Immune-Mediated Inflammatory Responses of Alveolar Epithelial Cells: Implications for COVID-19 Lung Pathology. Biomedicines, 2022
- Influenza A virus modulates ACE2 expression and SARS-CoV-2 infectivity in human cardiomyocytes. iScience, 2022
- Pre-Infection Innate Immunity Attenuates SARS-CoV-2 Infection and Viral Load in iPSC-Derived Alveolar Epithelial Type 2 Cells. Cells, 2024